A detailed history of Man Group PLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Man Group PLC holds 74,309 shares of CDXC stock, worth $520,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,309
Previous 17,545 323.53%
Holding current value
$520,906
Previous $61,000 231.15%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.44 - $4.32 $138,504 - $245,220
56,764 Added 323.53%
74,309 $202,000
Q1 2024

May 15, 2024

BUY
$1.36 - $3.84 $23,861 - $67,372
17,545 New
17,545 $61,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $479M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.